Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $541,806 - $1.05 Million
-268,221 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.66 - $10.92 $1.79 Million - $2.93 Million
268,221 New
268,221 $2.65 Million
Q1 2021

May 14, 2021

SELL
$4.59 - $18.74 $1.23 Million - $5.03 Million
-268,221 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$4.01 - $5.56 $40,100 - $55,599
-10,000 Reduced 3.59%
268,221 $1.08 Million
Q3 2019

Nov 08, 2019

BUY
$3.83 - $4.72 $38,300 - $47,200
10,000 Added 3.73%
278,221 $1.1 Million
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $863,671 - $1.19 Million
268,221 New
268,221 $995,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $360M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.